(E)-((E)-1-phenylpent-1-en-3-yl) 2-cyano-3-(3,4-dihydroxyphenyl)acrylate | 1579956-02-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (E)-((E)-1-phenylpent-1-en-3-yl) 2-cyano-3-(3,4-dihydroxyphenyl)acrylate
• 英文别名: [(E)-1-phenylpent-1-en-3-yl] (E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoate
• CAS: 1579956-02-7
• 化学式: C₂₁H₁₉NO₄
• 分子量: 349.386
• InChiKey: BBISGANYDGKLDE-WJISXQBPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  26
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  90.6
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  (E)-1-phenyl-1-penten-3-ol 在 哌啶 、 4-二甲氨基吡啶 、 N,N'-二环己基碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 反应 4.0h， 生成 (E)-((E)-1-phenylpent-1-en-3-yl) 2-cyano-3-(3,4-dihydroxyphenyl)acrylate
  参考文献：
  名称：

  Synthesis and structure–activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel

  摘要：

  The TWIK-related K+ channel, TREK-1, has recently emerged as an attractive therapeutic target for the development of a novel class of analgesic drugs. It has been reported that TREK-1 -/- mice were more sensitive than wild-type mice to painful stimuli, suggesting that activation of TREK-1 could result in pain inhibition. Here we report the synthesis of a series of substituted caffeate esters (12a-u) based on the hit compound CDC 2 (cinnamyl 3,4-dihydroxyl-alpha-cyanocinnamate). These analogs were evaluated for their ability to modulate TREK-1 channel by electrophysiology and for their in vivo antinociceptive activity (acetic acid induced-writhing assay) leading to the identification a series of novel molecules able to activate TREK-1 and displaying potent analgesic activity in vivo. (C) 2014 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2014.01.049

文献信息

• Synthesis and structure–activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel
  作者：Nuno Rodrigues、Khalil Bennis、Delphine Vivier、Vanessa Pereira、Franck C. Chatelain、Eric Chapuy、Hemantkumar Deokar、Jérôme Busserolles、Florian Lesage、Alain Eschalier、Sylvie Ducki

  DOI：10.1016/j.ejmech.2014.01.049

  日期：2014.3

  The TWIK-related K+ channel, TREK-1, has recently emerged as an attractive therapeutic target for the development of a novel class of analgesic drugs. It has been reported that TREK-1 -/- mice were more sensitive than wild-type mice to painful stimuli, suggesting that activation of TREK-1 could result in pain inhibition. Here we report the synthesis of a series of substituted caffeate esters (12a-u) based on the hit compound CDC 2 (cinnamyl 3,4-dihydroxyl-alpha-cyanocinnamate). These analogs were evaluated for their ability to modulate TREK-1 channel by electrophysiology and for their in vivo antinociceptive activity (acetic acid induced-writhing assay) leading to the identification a series of novel molecules able to activate TREK-1 and displaying potent analgesic activity in vivo. (C) 2014 Elsevier Masson SAS. All rights reserved.